Neurovascular thrombectomy market projected to quadruple by 2035

This is thanks to a rise in MVO interventions, shifts in device preference, and increasing prices.

The neurovascular thrombectomy devices market, valued at $1.2b, is expected to reach $5b by 2035, according to GlobalData.

The expansion is attributed to a rising number of medium vessel occlusion (MVO) interventions, shifts in device preference, and increasing device prices.

“The rising number of MVO interventions is driving changes in device design and selection, with aspiration catheters—particularly smaller-diameter models—gaining traction,” Ashley Clarke, Senior Medical Analyst at GlobalData, said.

Aspiration catheters are expected to account for 87% of the market value during the forecast period.

“Physicians prefer devices that enable simpler access, shorter procedure durations, and lower risk,” Clarke added.